Patrick Trojer
- Molecular Biology top 1%
- Epigenetics and DNA Methylation 36
- Cancer-related gene regulation 25
- Genomics and Chromatin Dynamics 15
- Histone Deacetylase Inhibitors Research 13
- Protein Degradation and Inhibitors 5
- Aging top 5%
- Cancer Research top 5%
- Hematology top 5%
- Multiple Myeloma Research and Treatments 6
- Chronic Myeloid Leukemia Treatments 5
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Co-authors
- Danny ReinbergRaphaël MargueronGuohong LiJohn P. McGrathBing ZhuSubhrangsu S. MandalRushad PavriAli Shilatifard
- Journals
- Blood (5 papers)Journal of Biological Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)
- Partner nations
- United StatesAustriaUnited Kingdom
In The Last Decade
Patrick Trojer
58 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Molecular Biology 4.7k
- Aging 50
- Cancer Research 318
- Hematology 221
- Genetics 483
Countries citing papers authored by Patrick Trojer
This map shows the geographic impact of Patrick Trojer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Trojer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Trojer more than expected).
Fields of papers citing papers by Patrick Trojer
This network shows the impact of papers produced by Patrick Trojer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Trojer. The network helps show where Patrick Trojer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Patrick Trojer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 23 | |
| 2 | 2021 | 9 | |
| 3 | 2020 | 49 | |
| 4 | 2019 | 36 | |
| 5 | 2018 | 24 | |
| 6 | Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapybreakdown → | 2018 | 182 |
| 7 | 2017 | 37 | |
| 8 | 2016 | 70 | |
| 9 | 2016 | 85 | |
| 10 | 2015 | 77 | |
| 11 | 2015 | 150 | |
| 12 | 2013 | 116 | |
| 13 | 2011 | 113 | |
| 14 | 2010 | 21 | |
| 15 | 2009 | 237 | |
| 16 | 2009 | 67 | |
| 17 | 2007 | 267 | |
| 18 | Histone H2B Monoubiquitination Functions Cooperatively with FACT to Regulate Elongation by RNA Polymerase IIbreakdown → | 2006 | 576 |
| 19 | 2006 | 174 | |
| 20 | 1999 | 6 |
About Patrick Trojer
Patrick Trojer is a scholar working on Hematology, Molecular Biology, Genetics, Transplantation and Oncology, having authored 58 papers that have together received 5.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (36 papers), Cancer-related gene regulation (25 papers), Genomics and Chromatin Dynamics (15 papers), Histone Deacetylase Inhibitors Research (13 papers), Multiple Myeloma Research and Treatments (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Protein Degradation and Inhibitors (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). The work is most often cited by research in Molecular Biology (4.7k citations), Aging (50 citations), Cancer Research (318 citations), Hematology (221 citations) and Genetics (483 citations). Patrick Trojer has collaborated with scholars based in United States, Austria and United Kingdom. Frequent co-authors include Danny Reinberg, Raphaël Margueron, Guohong Li, John P. McGrath, Bing Zhu, Subhrangsu S. Mandal, Rushad Pavri, Ali Shilatifard, Raffaella Villa and Kai-Ping Yan. Their work appears in journals such as Blood, Journal of Biological Chemistry, Bioorganic & Medicinal Chemistry Letters, Cell and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.